Cargando…
Subsequent Treatment after Transarterial Chemoembolization Failure/Refractoriness: A Review Based on Published Evidence
Transarterial chemoembolization (TACE) is widely applied for the treatment of hepatocellular carcinoma. Repeat TACE is often required in clinical practice because a satisfactory tumor response may not be achieved with a single session. However, repeated TACE procedures can impair liver function and...
Autores principales: | Zhang, Shen, Wang, Wan-Sheng, Zhong, Bin-Yan, Ni, Cai-Fang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
XIA & HE Publishing Inc.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9396332/ https://www.ncbi.nlm.nih.gov/pubmed/36062280 http://dx.doi.org/10.14218/JCTH.2021.00336 |
Ejemplares similares
-
Transarterial chemoembolization failure/refractoriness: A scientific concept or pseudo-proposition
por: Zhang, Shen, et al.
Publicado: (2022) -
Re-evaluating Transarterial Chemoembolization Failure/Refractoriness: A Survey by Chinese College of Interventionalists
por: Zhong, Bin-Yan, et al.
Publicado: (2021) -
How to Define Transarterial Chemoembolization Failure or Refractoriness: A European Perspective
por: Raoul, Jean-Luc, et al.
Publicado: (2014) -
Evaluation of transarterial chemoembolization refractoriness in patients with hepatocellular carcinoma
por: Choi, Jonggi, et al.
Publicado: (2020) -
Stratification of portal vein-invaded hepatocellular carcinoma treated with transarterial chemoembolization monotherapy
por: Zhang, Lei, et al.
Publicado: (2020)